Amaroq Ltd. awarded 2,254,467 Restricted Share Units (RSUs) to key executives, including the CEO and CFO, under its RSU Plan on April 10, 2026. These RSUs vest based on time and performance targets measured through December 31, 2028, with a two-year holding period for the CEO's award. Additionally, 20,927 RSUs vested recently for the Chief Corporate Development Officer, who sold some shares to cover taxes. The RSU shares are expected to begin trading on AIM on April 14, 2026, increasing the company's total issued shares to 465,462,030. This move aligns with Amaroq's strategy to incentivize management while advancing its mineral exploration projects in Greenland.
Willis Towers Watson, a global advisory firm, is poised for growth with a 25.3% potential stock upside, driven by new initiatives like KwantSure, a digital insurance sales channel for subcontractors, and a Geospatial Mortality Model to improve pensio...
AngioDynamics reported an 8% revenue increase to $86.6 million in Q4, driven by a 16.7% sales rise in its Med Tech division, notably from NanoKnife and AlphaVac products. H.C. Wainwright raised the price target from $16 to $19 and maintained a Buy ra...
PNC Financial Services Group reported Q2 2026 adjusted EPS of $4.85 and record revenue of $6.88 billion, surpassing analyst expectations. The growth was driven by a 15.5% rise in net interest income and a 31.4% increase in fee income, reflecting stro...
Greenlight, a leading cannabis operator, expanded its Ohio presence by opening four new dispensaries and adding in-state manufacturing, reaching the state's maximum allowed eight dispensaries. This move strengthens Greenlight's position in Ohio's lim...
Halper Sadeh LLC is investigating whether shareholders of Element Solutions Inc (ESI), Crinetics Pharmaceuticals (CRNX), and Solstice Advanced Materials (SOLS) are receiving fair treatment in their respective sale and merger transactions. The firm hi...
